Evogene Ltd. has announced its upcoming Annual General Meeting of Shareholders, scheduled for August 11, 2025, at its executive offices in Rehovot, Israel. Key proposals to be voted on include the re-election of current nominees and the election of the Company's CEO and President as a director, to serve until the next Annual General Meeting. The Board of Directors recommends voting in favor of these proposals. Shareholders are encouraged to submit their proxy votes promptly.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evogene Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-25-002403), on July 17, 2025, and is solely responsible for the information contained therein.